Skip to ContentSkip to Navigation
University of Groningenfounded in 1614  -  top 100 university
About us Practical matters How to find us prof. dr. P. (Peter) van der Meer

Publications

Association between body mass index and clinical outcomes in patients with acute myocardial infarction and reduced systolic function: Analysis of PARADISE-MI trial data

Bromocriptine treatment and outcomes in peripartum cardiomyopathy: the EORP PPCM registry

Cardiovascular Safety in Oncology Clinical Trials: JACC: CardioOncology Primer

Detecting early cardiomyopathy in transthyretin variant carriers: reappraising the diagnostic value of Perugini grade 1 radiotracer uptake on bone scintigraphy

Discharge Medication After Natriuresis-Guided Dosing of Diuretic Therapy in Patients Hospitalized for Acute Heart Failure: A PUSH-AHF Substudy

Empagliflozin in acute myocardial infarction in patients with and without type 2 diabetes: A pre-specified analysis of the EMPACT-MI trial

Glutathione deficiency and heart failure: a systematic review of human and animal evidence

Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohort

Is transthyretin amyloid cardiomyopathy heading towards losing its rare disease classification?

Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial

Press/media

ESC 2022 Gesprek van de dag | zaterdag

Gebruik van kaliumbinders in de klinische praktijk

Behandeling van hartfalen nu en in de toekomst

Niet-cardiale comorbiditeiten bij hartfalen

Gain-of-function mutation in ubiquitin ligase KLHL24 causes desmin degradation and dilatation in hiPSC-derived engineered heart tissues

Ijzerdeficiëntie bij hartfalen - doe mee aan de poll

Intraveneus ijzer bij patiënten met ijzerdeficiëntie, gestabiliseerd na acuut HF

Ziekenhuizen: geef ons personeel direct het vaccin

OUTPUT OR ACTIVITY: Hoe diagnosticeer en behandel je amyloïdose?